Evidence is not a marketing word here. It is the method.
Every recommendation we make is grounded in current evidence and society guidelines, explained in plain language — including the recommendation not to treat, when that is the right answer.
What "evidence-based" means in practice
Three commitments, kept visibly:
- Guidelines as the floor, not the ceiling. Care follows current recommendations from The Menopause Society and the Endocrine Society. Where guidelines and newer data diverge, we tell you that — and explain the reasoning behind our recommendation.
- Numbers, not adjectives. "Small risk" means a number here — like the roughly 9 additional breast cancer cases per 10,000 women per year with combined therapy in the WHI. You get absolute risks for your situation, framed against comparable everyday risks.
- Honest boundaries. Hormone therapy is not an anti-aging cure, is not used to prevent dementia or heart disease, and is not right for everyone. Claims that outrun the evidence get an honest appraisal — whether they come from a headline that scares you or a clinic that wants to sell you something.
Research is not decoration here
The practice runs clinical trials through its affiliated research center, EndoTrials, has published in peer-reviewed journals, and presented its own outcomes at ENDO 2026, the Endocrine Society's annual meeting. Physicians who generate evidence read it differently — more skeptically, and more usefully — than physicians who only consume the summary.
The training gap we exist to close
A 2023 survey found that while more than 90% of OB/GYN residency directors agreed menopause should be a standard part of training, fewer than a third of programs actually taught such a curriculum. Many clinicians women see in their 40s and 50s were simply never taught modern menopause management. We have made it a focus of the practice — and of this website, which is written by the physicians, not a content farm.